![Jacques Näsström](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jacques Näsström
Plus aucun poste en cours
Profil
Jacques Näsström worked as the Chief Executive Officer at Accuro Immunology AB. He then served as the Director of Cellular & Molecular Pharmacology at Astra AB from 1986 to 2001.
Dr. Näsström also held the position of Director at Cellectricon AB. From 2006 to 2010, he worked as the Research Director at Q-Med AB. He was also the Director at Independent Pharmaceutica AB. Prior to that, Dr. Näsström worked as an Investment Manager at Karolinska Investment Fund KB from 2001 to 2006.
He also served as the Principal at AngioGenetics AB. Currently, he is the Chief Scientific Officer & Vice President at Egetis Therapeutics AB, a position he has held since 2017.
In terms of education, Dr. Näsström holds an MBA from Stockholm School of Economics and a doctorate from the University of Uppsala.
Anciens postes connus de Jacques Näsström
| Sociétés | Poste | Fin |
|---|---|---|
| EGETIS THERAPEUTICS AB | Directeur Général | 16/06/2017 |
Q-Med AB
 Q-Med AB Medical SpecialtiesHealth Technology Develops, manufactures, markets, and sells medical implants for esthetic and medical use | Directeur Technique/Scientifique/R&D | 01/01/2010 |
Karolinska Investment Fund KB
 Karolinska Investment Fund KB Investment ManagersFinance Acts as Venture Capital Fund | Directeur en chef des Investissements | - |
Astra AB
 Astra AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals preparations | Corporate Officer/Principal | 01/01/2001 |
AngioGenetics AB
 AngioGenetics AB Pharmaceuticals: GenericHealth Technology Develops, markets, and distributes generic drugs | Corporate Officer/Principal | - |
Formation de Jacques Näsström
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
31
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Astra AB
Astra AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals preparations | Health Technology |
Cellectricon AB
 Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Provides cell-based screening services to accelerate drug discovery | Commercial Services |
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Develops, manufactures, markets, and sells medical implants for esthetic and medical use | Health Technology |
Stockholm School of Economics
 Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Accuro Immunology AB
 Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Develops and manufactures active immunotherapy products | Health Technology |
Karolinska Investment Fund KB
Karolinska Investment Fund KB Investment ManagersFinance Acts as Venture Capital Fund | Finance |
AngioGenetics AB
AngioGenetics AB Pharmaceuticals: GenericHealth Technology Develops, markets, and distributes generic drugs | Health Technology |
Independent Pharmaceutica AB
 Independent Pharmaceutica AB Medical DistributorsDistribution Services Provides pharmacological solutions for treatment of nicotine addiction. | Distribution Services |
Egetis Therapeutics AB
 Egetis Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Choisissez Zonebourse 
